Aurobindo Pharma consolidated net profit rises 26.00% in the September 2020 quarter
Sales rise 15.58% to Rs 6377.91 crore
Net profit of Aurobindo Pharma rose 26.00% to Rs 806.23 crore in the quarter ended September 2020 as against Rs 639.86 crore during the previous quarter ended September 2019. Sales rose 15.58% to Rs 6377.91 crore in the quarter ended September 2020 as against Rs 5518.27 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales6377.915518.27 16 OPM %22.1420.66 -PBDT1450.321119.97 29 PBT1192.98876.66 36 NP806.23639.86 26Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content